Motavizumab - CISMeF

Preferred Label : Motavizumab;

NCIt synonyms : Immunoglobulin G1, anti-(respiratory syncytial virus glocoprotein F) (human-mouse monoclonal MEDI-524 gamma-1-chain), disulfide with human-mouse monoclonal MEDI-524 kappa-chain, dimer;

NCIt definition : A humanized monoclonal antibody directed against the respiratory syncytial virus (RSV) fusion glycoprotein (F-protein), with activity against RSV. Motavizumab targets and binds to the RSV F-protein, which prevents F-protein-mediated RSV fusion with human host cells. This protects against RSV infection. RSV F-protein mediates RSV attachment and fusion to host cells.;

UNII : 50Y163LK8Q;

CAS number : 677010-34-3;

Molecule name : MEDI-524;

Details

Origin ID

C88584;

UMLS CUI

C2713599;

Automatic exact mappings (from CISMeF team)
- Motavizumab [ICD-11 Extension code]
Currated CISMeF NLP mapping
- motavizumab [MeSH concept]
- motavizumab [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- motavizumab [ATC Code]
- motavizumab [MeSH Supplementary Concept]
- motavizumab [MeSH concept]
Validated automatic mappings to BTNT
- motavizumab [ATC Code]
chemical_or_drug_has_mechanism_of_action
- Antigen Binding [NCIt concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients